[Updated, 11/9/16, 1:20 p.m. See below.] The 2016 U.S. election is over. The country has been rocked by the presidential race, with Donald Trump taking the White House.
Every facet of American policy, our attitudes toward power and governance,... Read more »
Aquaculture company AquaBounty Technologies has scrapped plans to use a broad equity offering to raise the money it needs to bring its genetically engineered salmon to consumers. Instead, it has inked a deal to raise funds by selling securities to synthetic... Read more »
From a hack of Democratic National Committee e-mails to fears that cyber attackers will attempt to interfere with tomorrow’s election, cybersecurity emerged as a crucial theme in this grueling presidential campaign.
Neither candidate has said a lot about how he or... Read more »
Our previous roundup came out last week before news broke that Susan Lindquist, a highly decorated and thoughtful researcher into the inner workings of proteins, passed away. She was 67.
First at the University of Chicago and then MIT’s Whitehead... Read more »
The polls are tightening. Millions of people are still making up their minds. National figures are making last-minute pitches. The decision could have huge implications for people across the U.S.
We’re talking of course about next week’s vote on Proposition 61... Read more »
Since its inception more than nine years ago, Xconomy has focused its coverage on the business of high technology—across information technology, life sciences, healthcare, energy, robotics, and much more. But underlying all that, in a sense, is education. We have long... Read more »
With election day less than a week away, voters are trying to imagine what turns the country might take under each of the presidential hopefuls. Tech entrepreneurs are likely considering how hospitable the new leadership might be to their specific industry... Read more »
It’s fall harvest now, and AgTech Accelerator has something new to show from the summer growing season: $8.5 million in additional funding that positions the accelerator to start planting investments in promising agriculture technologies from around the country.
The new funding... Read more »
Drugs that treat a form of vision loss known as age related macular degeneration aren’t just big business. They’re also a controversial part of the national debate over high drug prices, and their increased use has put ophthalmologists in the crosshairs... Read more »